Brief: Cyclacel Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
June 3 (Reuters) - Cyclacel Pharmaceuticals Inc CYCC.O: CYCLACEL PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT Source text: ID:nGNXxYRzd Further company coverage: CYCC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bio Green Med Solution
See all newsBrief: Bio Green Med Solution Announces Business Combination Agreement To Acquire Future NRG
Bio Green Med Solution Q1 product revenue hits $0.8 mln, net loss narrows
Brief: Bio Green Med Solution Inc Q1 Net Income USD -197 Thousand
Malaysia's Bio Green Med Solution Q4 net loss narrows
Brief: Bio Green Med Solution Inc Q4 Net Income USD -611 Thousand